β-Carotene and lycopene affect endothelial response to TNF-α reducing nitro-oxidative stress and interaction with monocytes

Mol Nutr Food Res. 2012 Feb;56(2):217-27. doi: 10.1002/mnfr.201100500. Epub 2011 Dec 9.

Abstract

Scope: Cardiovascular disease (CVD) is associated with vascular oxidative imbalance and inflammation. Increased reactive oxygen species (ROS) generation is associated with a functional inactivation of nitric oxide (NO) due to the reaction with O₂⁻, leading to peroxynitrite (ONOO⁻) formation and subsequent reduction in the beneficial effect of vascular NO bioavailability. Carotenoids'-rich diets have been associated with decreased risk of CVD, but the underlying mechanism is still unknown.

Methods and results: In human umbilical vein endothelial cells (HUVECs), both β-carotene (BC) or lycopene (Lyc) significantly affected tumor necrosis factor-α (TNF-α)-induced inflammation, being associated with a significant decrease in the generation of ROS (spectrofluorometry) and nitrotyrosine (an index of ONOO⁻ formation, cytofluorimetry), an increased NO/cGMP (cyclic guanosine monophosphate) levels (EIA), and a down-regulation of NF-κB-dependent adhesion molecule expression (Western blot and EMSA) and monocyte-HUVEC interaction (adhesion assay). Our results indicate that BC or Lyc treatment reduce the inflammatory response in TNF-α-treated HUVECs. This is due to the redox balance protection and to the maintenance of NO bioavailability.

Conclusion: Our observations provide background for a novel mechanism for carotenoids' anti-inflammatory activity in the vasculature and may contribute to a better understanding of the protective effects of carotenoid-rich diets against CVD risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Biological Availability
  • Carotenoids / pharmacokinetics
  • Carotenoids / pharmacology*
  • Cell Adhesion / drug effects
  • Cell Adhesion Molecules / metabolism
  • Cyclic GMP / metabolism
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Lycopene
  • Monocytes / cytology
  • Monocytes / drug effects*
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Oxidative Stress / drug effects*
  • Reactive Oxygen Species / metabolism
  • Tumor Necrosis Factor-alpha / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • beta Carotene / pharmacokinetics
  • beta Carotene / pharmacology*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cell Adhesion Molecules
  • NF-kappa B
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • beta Carotene
  • Nitric Oxide
  • Carotenoids
  • 3-nitrotyrosine
  • Tyrosine
  • Cyclic GMP
  • Lycopene